Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy. [electronic resource]
Producer: 20050830Description: 379-87 p. digitalISSN:- 0169-5002
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Cost Control
- Deoxycytidine -- administration & dosage
- Health Care Costs -- statistics & numerical data
- Health Services -- statistics & numerical data
- Humans
- Italy
- Lung Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Retrospective Studies
- Vinblastine -- administration & dosage
- Vinorelbine
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.